AFK Periodontics: 2017 Staging, Surgery, Most-Tested Topics

Periodontology accounts for roughly eight percent of the AFK blueprint, but it carries disproportionate weight on exam day. Perio stems are predictable, the answer key follows the 2017 AAP/EFP classification almost line-for-line, and most candidates lose marks because they revised from a textbook that still teaches "chronic versus aggressive periodontitis." That framework was retired in 2017. This review walks through staging and grading, peri-implant disease criteria, regenerative surgery highlights, and the ten topics the NDEB tests most often — with five sample MCQs and rationales.

The 2017 AAP Classification: What Actually Changed

The 2017 World Workshop replaced "chronic" and "aggressive" periodontitis with a single disease entity — periodontitis — described by stage (severity and complexity) and grade (rate of progression and risk). Aggressive periodontitis is gone; what used to be called aggressive disease now appears as Stage III or IV, Grade C. Necrotising forms remain a separate category, as do periodontitis as a manifestation of systemic disease. Peri-implant diseases received their own classification in the same workshop.

Case definition: interdental clinical attachment loss (CAL) detectable at two or more non-adjacent teeth, or buccal/oral CAL ≥3 mm with pocketing >3 mm at two or more teeth — provided the loss is not attributable to non-periodontal causes (trauma recession, caries, endodontic lesions). Once met, every patient gets both a stage and a grade.

Supracrestal tissue attachment is the new term for biologic width — junctional epithelium plus connective tissue coronal to the alveolar crest, averaging about 2.04 mm. Violation by deep subgingival margins drives chronic inflammation and is a classic restorative-perio crossover distractor.

Staging by CAL, Bone Loss, and Complexity

Staging captures severity at the worst-affected site and the complexity of management required. Interdental CAL is the primary staging variable; radiographic bone loss and tooth loss attributable to periodontitis serve as confirmatory and modifying criteria.

Stage	Interdental CAL (worst site)	Radiographic bone loss	Tooth loss (perio)	Complexity factors
I	1–2 mm	Coronal third (<15%)	None	Maximum probing depth ≤4 mm; mostly horizontal bone loss
II	3–4 mm	Coronal third (15–33%)	None	Maximum probing depth ≤5 mm; mostly horizontal bone loss
III	≥5 mm	Extending to mid-third and beyond	≤4 teeth	PD ≥6 mm, vertical bone loss ≥3 mm, Class II/III furcation, moderate ridge defect
IV	≥5 mm	Extending to mid-third and beyond	≥5 teeth	All Stage III plus: masticatory dysfunction, secondary occlusal trauma (mobility ≥2), bite collapse, fewer than 20 remaining teeth (10 opposing pairs)

The most common AFK trap is staging on probing depth alone. PD is not a staging variable — CAL is. A 7 mm pocket with 2 mm of recession reflects 9 mm of attachment loss, which is Stage III on its own. Second trap: tooth loss "due to periodontitis" must be attributable to perio, not caries, fracture, or failed endodontics. Stage IV is reserved for cases where rehabilitation needs go beyond perio therapy.

Grading by Progression, Smoking, and Diabetes

Grade describes how fast the disease is moving and how the patient's risk profile modifies the prognosis. The grade starts at B by default and is shifted up to C or down to A based on direct or indirect evidence of progression and on two risk factors — smoking and diabetes — that the workshop singled out as grade modifiers.

Grade	Progression evidence	Smoking	Diabetes (HbA1c)	Bone loss / age ratio
A (slow)	No loss over 5 years; heavy biofilm, low destruction	Non-smoker	Normoglycaemic / no diagnosis	<0.25
B (moderate)	<2 mm loss over 5 years	<10 cigarettes/day	HbA1c <7.0% in diabetic	0.25–1.0
C (rapid)	≥2 mm loss over 5 years; destruction exceeds biofilm; molar-incisor pattern	≥10 cigarettes/day	HbA1c ≥7.0% in diabetic	>1.0

When 5-year data is unavailable — true of most exam vignettes — use the indirect indicator: percent radiographic bone loss at the worst site divided by patient age. A 25-year-old with 50 percent bone loss has a ratio of 2.0, which is Grade C regardless of smoking or diabetes. This is how the old "aggressive periodontitis" picture now enters the system. Heavy smoking (≥10/day) or HbA1c ≥7.0% shifts B to C even when progression looks moderate.

Peri-Implant Health, Mucositis, and Peri-Implantitis

The 2017 workshop gave peri-implant tissues their own three-tier classification. The discriminator is bleeding on probing first, then radiographic bone loss.

Peri-implant health: absence of bleeding, suppuration, and inflammation, with no progressive bone loss beyond first-year remodelling (typically up to 2 mm). PD is not a fixed cut-off — implants can be healthy at deeper depths than teeth because of the longer transmucosal component.

Peri-implant mucositis: bleeding on gentle probing (≤0.25 N) with or without erythema, swelling, or suppuration, and no bone loss beyond initial remodelling. The implant analogue of gingivitis — reversible with biofilm control.

Peri-implantitis: bleeding and/or suppuration on probing, increased PD versus baseline, and progressive bone loss beyond initial remodelling. When baseline records are missing, the case definition accepts PD ≥6 mm together with bone levels ≥3 mm apical to the most coronal portion of the intra-osseous part of the implant. Risk factors the AFK reuses: history of periodontitis, poor plaque control, lack of supportive therapy, smoking, and diabetes.

Try the AFK perio diagnostic at Lumen to find out where your staging and grading reflexes stand before you commit to a study plan.

Regenerative Procedures: GTR, EMD, and GBR

Regenerative stems anchor to three procedures and the defects they treat.

Guided tissue regeneration (GTR) uses a barrier membrane to exclude epithelium and gingival connective tissue so periodontal ligament and bone cells repopulate the root surface. Classical indications: two- or three-wall intrabony defects ≥3 mm, or Class II mandibular furcations. Resorbable collagen membranes have largely replaced non-resorbable PTFE; titanium-reinforced PTFE persists for ridge augmentation.

Enamel matrix derivative (EMD, Emdogain) is a porcine enamel protein extract applied to a conditioned root surface to mimic developmental cementogenesis. Best evidence supports narrow, deep intrabony defects; furcation results are less predictable. EMD doesn't require a membrane in narrow defects — the gel maintains space.

Guided bone regeneration (GBR) is the implant-site analogue of GTR — barrier plus graft to rebuild ridge volume before or during placement. Autogenous bone is the osteogenic gold standard; allografts and xenografts dominate in practice. Class III furcations and one-wall intrabony defects do not regenerate predictably with any technique and are managed with resective surgery, root resection, or extraction.

5 Sample MCQs

1. A 32-year-old non-smoker has 6 mm interdental CAL on the maxillary first molars and central incisors, 60% bone loss at those sites, no tooth loss, and HbA1c 5.4%. Diagnosis? A. Stage II, Grade B B. Stage III, Grade B C. Stage III, Grade C D. Stage IV, Grade C

Answer: C. CAL ≥5 mm with mid-third bone loss and no qualifying tooth loss is Stage III. Bone loss/age ratio = 60/32 ≈ 1.9 (>1.0), so Grade C despite no smoking or diabetes. Stage IV needs ≥5 teeth lost or major rehab needs.

2. The case definition of peri-implantitis when baseline radiographs are unavailable is: A. Bleeding on probing alone B. PD ≥4 mm with bleeding C. Bleeding/suppuration plus PD ≥6 mm and bone ≥3 mm apical to the coronal intra-osseous implant portion D. Mobility plus radiolucency

Answer: C. The 2017 criteria accept this combination when baseline is missing. Mobility indicates failed osseointegration, not peri-implantitis.

3. Supracrestal tissue attachment ("biologic width") averages approximately: A. 1.0 mm B. 2.0 mm C. 3.0 mm D. 4.0 mm

Answer: B. Roughly 2.04 mm — about 1 mm junctional epithelium plus 1 mm connective tissue attachment.

4. A 4 mm-deep, narrow three-wall intrabony defect on the mesial of #46. Most predictable regenerative option? A. Open flap debridement alone B. Apically positioned flap C. EMD with or without bone graft D. Hemisection

Answer: C. Narrow, deep, multi-wall intrabony defects are the textbook indication for EMD and/or GTR. OFD gives repair, not regeneration; apically positioned flaps are resective; hemisection is for furcation-involved molars with one salvageable root.

5. The 2017 classification eliminated which standalone diagnosis? A. Necrotising periodontitis B. Aggressive periodontitis C. Periodontitis as a manifestation of systemic disease D. Peri-implant mucositis

Answer: B. Folded into staging and grading — typically Stage III/IV, Grade C. The other three remain valid.

Top 10 Most-Tested Periodontics Topics

1. 2017 staging by CAL and bone loss — the single highest-yield perio item.
2. 2017 grading and the bone loss/age ratio — usually paired with smoking or diabetes.
3. Peri-implantitis case definition — the no-baseline criteria (PD ≥6 mm, bone ≥3 mm) recur verbatim.
4. Furcation classification (Glickman or Hamp) — Class II is treatable; Class III usually isn't.
5. Supracrestal tissue attachment violation — restorative-perio crossover; subgingival margins.
6. Necrotising periodontal diseases — pain, ulceration, pseudomembrane, fetor; HIV and stress modifiers.
7. Drug-induced gingival enlargement — phenytoin, cyclosporine, calcium channel blockers.
8. Adjunctive systemic antibiotics — amoxicillin plus metronidazole for Grade C.
9. Regenerative versus resective indications — multi-wall intrabony regenerates; one-wall and Class III furcations don't.
10. Maintenance recall intervals — 3-month recall is the default after active therapy in moderate-to-severe cases.

FAQ

What is the 2017 AAP classification? A unified framework that replaced "chronic" and "aggressive" periodontitis with a single disease — periodontitis — described by stage (I–IV) and grade (A–C). It also created a standalone classification for peri-implant health, mucositis, and peri-implantitis.

When did aggressive periodontitis go away? At the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases. The AFK uses the post-2017 framework, so vignettes featuring rapid molar-incisor destruction are now Stage III or IV, Grade C.

What's Stage III versus Stage IV? Both share CAL ≥5 mm and bone loss into the mid-third or beyond. Stage III caps tooth loss at four and complexity at vertical bone loss, Class II/III furcations, and moderate ridge defects. Stage IV adds ≥5 teeth lost, masticatory dysfunction, secondary occlusal trauma (mobility ≥2), bite collapse, or fewer than 20 remaining teeth.

How is peri-implantitis diagnosed? Bleeding and/or suppuration on probing, increased PD versus baseline, and progressive bone loss beyond initial remodelling. Without baseline data, PD ≥6 mm with bone levels ≥3 mm apical to the coronal intra-osseous implant portion is sufficient.

What is supracrestal tissue? The renamed "biologic width" — connective tissue attachment plus junctional epithelium, roughly 2 mm coronal to the alveolar crest. Restorative margins placed within this zone produce chronic inflammation that does not resolve with hygiene alone.

Do I need to memorise bone loss percentages? Know the conceptual cut-offs: coronal third, mid-third, and beyond. Exact percentages matter only for the bone loss/age ratio in grading, where any ratio above 1.0 is Grade C.

Which textbook should I revise from? Newman and Carranza's Clinical Periodontology (13th edition). Pair the staging and grading chapters with the Caton et al. 2018 consensus paper — the AFK answer key tracks its tables.

Build your AFK study schedule with Lumen — the perio module locks in 2017-classification reps and tracks your accuracy on the exact stem patterns the NDEB reuses.

For the broader picture: AFK exam overview, 2026 topic weights, biomedical study guide, how to pass the AFK, and the Lumen blog.

Sources: Caton et al. A new classification scheme for periodontal and peri-implant diseases and conditions. J Periodontol 2018;89(S1):S1–S8 / J Clin Periodontol 2018;45(S20):S1–S8. Newman & Carranza's Clinical Periodontology, 13th ed.